{"id":"https://openalex.org/W4403554681","doi":"https://doi.org/10.1016/j.htct.2024.09.1156","title":"BRIDGING THE GAP IN POST-TRANSPLANT CARE FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): INNOVATIVE MAINTENANCE STRATEGIES TO REDUCE RELAPSE RATE AND ENHANCE SURVIVAL","display_name":"BRIDGING THE GAP IN POST-TRANSPLANT CARE FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): INNOVATIVE MAINTENANCE STRATEGIES TO REDUCE RELAPSE RATE AND ENHANCE SURVIVAL","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403554681","doi":"https://doi.org/10.1016/j.htct.2024.09.1156"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2024.09.1156","doi":"https://doi.org/10.1016/j.htct.2024.09.1156","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1156","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4403554681"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2024.09.1156","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023907554","display_name":"Carla Nolasco Monteiro Breviglieri","orcid":"https://orcid.org/0000-0002-6089-5526","observed_orcids":["https://orcid.org/0000-0002-6089-5526"]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"CNM Breviglieri","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100861356","display_name":"CN Santos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"CN Santos","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112354378","display_name":"Rosemeire O. Vasconcelos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"RG Vasconcelos","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032713688","display_name":"VC Ginani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"VC Ginani","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071125709","display_name":"ABW Batalha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"ABW Batalha","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":null,"display_name":"MRS Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"MRS Oliveira","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":null,"display_name":"GS Alencar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"GS Alencar","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014147073","display_name":"JF Marques","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"JF Marques","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055586226","display_name":"Adriana Seber","orcid":"https://orcid.org/0000-0003-4578-9423","observed_orcids":["https://orcid.org/0000-0003-4578-9423"]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"A Seber","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210097205"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":null,"first_page":"S688","last_page":"S689"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/childhood-acute-lymphoblastic-leukemia","display_name":"childhood acute lymphoblastic leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/post-transplant-maintenance-therapy","display_name":"post-transplant maintenance therapy","score":0.828000009059906},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.7459999918937683},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8309999704360962},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/inotuzumab","display_name":"inotuzumab","score":0.9279999732971191},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.8790000081062317},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.996999979019165},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.722000002861023},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.6790000200271606},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8759999871253967},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8309999704360962},{"id":"https://openalex.org/keywords/graft-function","display_name":"graft function","score":0.6100000143051147},{"id":"https://openalex.org/keywords/graft-failure","display_name":"graft failure","score":0.3179999887943268}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9200398921966553},{"id":"https://openalex.org/C174348530","wikidata":"https://www.wikidata.org/wiki/Q188635","display_name":"Bridging (networking)","level":2,"score":0.8720834255218506},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.7682839035987854},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5071406364440918},{"id":"https://openalex.org/C2909143077","wikidata":"https://www.wikidata.org/wiki/Q5097977","display_name":"Pediatric oncology","level":3,"score":0.4587678015232086},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38392573595046997},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3343196511268616},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.30662456154823303},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22484713792800903},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.04893416166305542},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2024.09.1156","doi":"https://doi.org/10.1016/j.htct.2024.09.1156","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1156","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:dde0e2390c9542799a4ba743309d9af4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dde0e2390c9542799a4ba743309d9af4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S688-S689 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2024.09.1156","doi":"https://doi.org/10.1016/j.htct.2024.09.1156","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1156","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7126172071","https://openalex.org/W4403554561","https://openalex.org/W4408158935","https://openalex.org/W4415351240","https://openalex.org/W3094797634","https://openalex.org/W2757776684","https://openalex.org/W4404902456","https://openalex.org/W2979532771","https://openalex.org/W4377221156","https://openalex.org/W4310119582"],"abstract_inverted_index":{"Relapsed":[0],"Acute":[1],"Lymphoblastic":[2],"Leukemia":[3],"(ALL)":[4],"post-hematopoietic":[5],"stem":[6],"cell":[7],"transplantation":[8],"(HCT)":[9],"have":[10],"very":[11],"poor":[12,246],"outcomes.":[13,64],"Patients":[14],"face":[15],"increased":[16],"toxicity":[17,35],"and":[18,33,62,81,88,101,107,123,130,159,201,269,282,285,292,307,352,369],"poorer":[19],"responses":[20],"to":[21,26,140,320,364],"therapy.":[22,111],"With":[23],"limited":[24],"access":[25],"Chimeric":[27],"Antigen":[28],"Receptor":[29],"(CAR)":[30],"T-cell":[31,86],"therapy,":[32],"the":[34,48,160,165,189,193,224,317],"of":[36,50,71,142,154,182,209,238,302,346],"a":[37,68,206,235,343,373],"second":[38],"HCT,":[39],"alternative":[40],"strategies":[41],"are":[42],"critically":[43],"needed.":[44],"Objective:":[45],"To":[46],"evaluate":[47],"impact":[49],"novel":[51],"maintenance":[52,110,113,155,172,200,277,312,329,347,366],"therapies":[53,114],"post-HCT":[54],"in":[55,261,349,354,372],"pediatric":[56,73,355],"ALL":[57,74,90,356],"on":[58,126,157],"reduce":[59],"relapse":[60,177,300,318,335],"rates":[61,336],"survival":[63],"Methods:":[65],"This":[66],"is":[67],"retrospective":[69],"study":[70],"64":[72],"patients":[75,167,195,216,226,323],"who":[76,102,185,217,227,273,287,326],"underwent":[77,171,327],"HCT":[78,100],"between":[79],"2014":[80],"2024.":[82],"From":[83],"2021":[84],"on,":[85],"ALL,":[87],"B-cell":[89],"transplanted":[91,148],"with":[92,168,174,196,234,324],"measurable":[93],"disease,":[94,97],"primary":[95],"refractory":[96],"or":[98,249],"post-second":[99],"had":[103,245],"adequate":[104],"clinical":[105,131],"conditions":[106],"access,":[108],"received":[109,199,218],"The":[112,151,264],"included":[115],"tyrosine":[116],"kinase":[117],"inhibitors,":[118],"blinatumomab,":[119,219],"inotuzumab,":[120],"hypomethylating":[121],"agents":[122],"venetoclax.":[124],"Data":[125],"demographics,":[127],"treatment":[128],"regimens,":[129],"outcomes":[132],"were":[133,147,279,289],"retrospectively":[134],"collected.":[135],"Results:":[136],"Maintenance":[137,297],"was":[138,156,255,313],"administered":[139],"38%":[141],"patients.":[143],"All":[144],"but":[145],"three":[146],"after":[149,205,252],"2020.":[150],"median":[152,207,236],"start":[153],"D+52":[158],"duration":[161],"6":[162,170],"months.":[163],"Of":[164,192,223],"10":[166,215],"T-ALL,":[169],"therapy":[173,278,298,330,348],"only":[175],"1":[176],"(16%),":[178],"while":[179],"2":[180,220],"out":[181],"4":[183],"(50%)":[184],"did":[186,228,274],"not":[187,229,275],"receive":[188,230,276],"prophylaxis":[190],"relapsed.":[191],"54":[194],"B-ALL,":[197],"18":[198],"5":[202],"relapsed":[203,221,233],"(27%)":[204],"time":[208,237,271],"273":[210,303],"days":[211,240],"(137-535":[212],"days).":[213,242],"Considering":[214],"(20%).":[222],"36":[225],"maintenance,":[231],"31%":[232],"105":[239,305],"(63-615":[241],"No":[243],"patient":[244],"graft":[247,250],"function":[248],"failure":[251],"maintenance.":[253],"There":[254],"no":[256],"mortality":[257],"from":[258],"infectious":[259],"causes":[260],"this":[262],"group.":[263],"overall":[265,309],"survival,":[266,268],"disease-free":[267],"follow-up":[270],"for":[272,286],"46%,":[280],"45%,":[281],"56":[283],"months,":[284,294],"did,":[288],"74%,":[290],"67%,":[291],"22":[293],"respectively.":[295],"Conclusion:":[296],"delayed":[299],"(median":[301],"vs":[304,338],"days)":[306],"improved":[308],"survival.":[310],"Blinatumomab":[311],"notably":[314],"effective,":[315],"reducing":[316],"rate":[319],"20%.":[321],"Similarly,":[322],"T-ALL":[325],"venetoclax-based":[328],"also":[331],"experienced":[332],"significantly":[333],"lower":[334],"(16%":[337],"50%).":[339],"Our":[340],"findings":[341,371],"suggest":[342],"substantial":[344],"benefit":[345],"enhancing":[350],"DFS":[351],"OS":[353],"post-HCT.":[357],"These":[358],"promising":[359],"results":[360],"support":[361],"further":[362],"research":[363],"refine":[365],"strategi":[367],"es":[368],"validate":[370],"larger":[374],"cohort.":[375]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2024-10-19T00:00:00"}